查詢結果分析
來源資料
頁籤選單縮合
| 題 名 | Suprasellar Meningiomas: Analysis of 32 Cases=上蝶鞍部腦膜瘤--32病例之分析 |
|---|---|
| 作 者 | 任森利; 李良雄; | 書刊名 | 中華醫學雜誌 |
| 卷 期 | 59:1 1997.01[民86.01] |
| 頁 次 | 頁7-14 |
| 分類號 | 416.291 |
| 關鍵詞 | 鞍隔膜; 蝶骨平面; 上蝶鞍部腦膜瘤; 鞍結節; Diaphragma sellae; Planum sphenoidale; Suprasellar meningioma; Tuberculum sellae; |
| 語 文 | 英文(English) |
| 中文摘要 | 背景:從鞍結節、鞍隔膜及蝶骨平面長出的上蝶鞍部腦膜瘤,是一種不常見的腦膜瘤。長在這個區域的腦瘤,經常造成不知不覺的視力缺失,而且常常到了腫瘤變得非常大或症狀加劇才被診斷出來。以前有作者指出腫瘤的大小及症狀持續的時間是影響病人預後的主要因素。本文討論過去十一年來我們的經驗與結果。 方法:從1984年至1995年共有32例經組織病理檢查證實的腦膜瘤病例入院接受手術治療。此32例之腫瘤均由上蝶鞍部生長出來。本文乃回顧這些病例的記錄,並且分析其臨床資料。 結果:腫瘤的直徑從1.4公分到6.4公分(平均3.4公分)。病人的年齡最小為15歲,最大為 70歲(平均49歲),最常發生於五十歲之年齡層。男女比例為7:25;其中每個年齡層均是女性佔多數,住院時的症狀大多為視力缺失(87.5%)。症狀持續的時間最短為2個月,最長達35年之久(平均為4.25年)。預後乃依據腫瘤的大小及症狀持續的時間來評估。我們得到以下的結果:腫瘤直徑小於或等於3公分及症狀持續時間小於或等於1年者預後較佳。 結論:分析32病例之資料,我們得到的結論為:若腫瘤直徑小於或等於3公分且症狀持續之時間小於或等於1年,則手術治療會有較好的視力預後、較高的腫瘤全切除率及較低的死亡率和復發率。 |
| 英文摘要 | Background: Suprasellar meningiomas originating from the tuberculum sellae, diaphragma sellae and planum sphenoidale are uncommon. Tumors of these regions can cause insidious visual loss and often remain undiagnosed until they have enlarged substantially or the symptoms have become aggravated. Previous reports have identified tumor size and duration of symptoms as the major factors determining the patient outcome. Methods: Between 1984 and 1995, at the Department of Neurosurgery, Neurological Institute of Veterans General Hospital-Taipei, 32 patients with histopathologically identified meningiomas originating from the suprasellar region received surgical tumor removal. In this study, the records and clinical data of these patients are retrospectively analyzed. Results: Tumor sizes ranged from 1.4 to 6.4 cm (average 3.4 cm) in diameter. The age of the patients ranged from 15 to 70 years (average 49 years), with the highest number of patients in their 50s. The male to female ratio was 7:25, with female predominance in all age groups. The presenting symptoms were mostly visual loss (87.5%) and the duration of symptoms ranged from 2 months to 35 years (average 4.25 years). Prognosis was evaluated according to the tumor size and duration of symptoms. Results showed that prognosis was favorably affected by a tumor size of 3.0 cm or less, and symptom duration of one year or less. Conclusions: In this series, patients with a tumor size of 3 cm or less and patients with a duration of symptoms for one year or less had a better visual outcome, higher total removal rates, lower mortality rates and lower recurrence rates. |
本系統中英文摘要資訊取自各篇刊載內容。